Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Endo Int'l Plc (ENDP)

Endo Int'l Plc (ENDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,803
  • Shares Outstanding, K 235,143
  • Annual Sales, $ 2,993 M
  • Annual Income, $ -613,250 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.15
  • Price/Sales 0.02
  • Price/Cash Flow 0.06
  • Price/Book N/A
  • Price/Earnings ttm 0.13
  • Earnings Per Share ttm 2.33
  • Most Recent Earnings $0.03 on 08/09/22
  • Next Earnings Date 08/11/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.13
  • Number of Estimates 2
  • High Estimate 0.16
  • Low Estimate 0.10
  • Prior Year 0.80
  • Growth Rate Est. (year over year) -83.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2800 +4.50%
on 08/17/22
0.9400 -68.87%
on 08/03/22
-0.1574 (-34.98%)
since 07/25/22
3-Month
0.2800 +4.50%
on 08/17/22
0.9400 -68.87%
on 08/03/22
-0.1047 (-26.35%)
since 05/25/22
52-Week
0.2800 +4.50%
on 08/17/22
7.0652 -95.86%
on 11/11/21
-2.2374 (-88.43%)
since 08/25/21

Most Recent Stories

More News
Purdue Pharma's Settlement Blocked; Opioid Crisis Accountability in Focus

The U.S. Supreme Court on Thursday blocked Purdue Pharma's bankruptcy settlement, which would have shielded the Sackler family from lawsuits related to their role in the opioid crisis. The decision reversed...

JNJ : 152.58 (-0.43%)
ENDP : 0.2926 (-5.00%)
TEVA : 16.62 (-1.89%)
MNK : 0.3402 (-14.97%)
ABC : 179.98 (-0.23%)
CAH : 123.02 (-1.84%)
MCK : 612.98 (-1.86%)
C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation

/CNW/ - C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), have partnered to launch a complimentary clinical testing...

ENDP : 0.2926 (-5.00%)
C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation

/PRNewswire/ - C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), have partnered to launch a complimentary clinical...

ENDP : 0.2926 (-5.00%)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data

Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GLP-1/GLP

VKTX : 55.08 (+0.04%)
AMGN : 296.77 (-1.55%)
LLY : 790.91 (-2.57%)
ENDP : 0.2926 (-5.00%)
PFE : 26.32 (-1.50%)
ALT : 8.50 (-10.71%)
Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthen Financial Position and Advance Ongoing Business Transformation

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo" or the "Company") today announced that it has entered into a restructuring support agreement...

ENDP : 0.2926 (-5.00%)
New Drug Filing for Cenobamate Accepted for Review in Canada and Israel

/PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd. announced that Health Canada has accepted Paladin Labs Inc.'s filing of a New Drug Submission (NDS) for...

ENDP : 0.2926 (-5.00%)
ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS

/CNW/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINANCIAL...

ENDP : 0.2926 (-5.00%)
ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINANCIAL...

ENDP : 0.2926 (-5.00%)
Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Adjunctive Therapy for the Management of Partial-Onset Seizures in Adults with Epilepsy

/CNW/ -- Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), announced today that Health Canada has accepted its New Drug Submission...

ENDP : 0.2926 (-5.00%)
Buxton Helmsley Issues Letter to Endo International Plc. Directors, Relating to Financial Disclosures

The Buxton Helmsley Group, Inc. (together with certain of its affiliates and clients, “BHG” or “we”), the New York City-based investment advisor to clients with financial interests in Endo International...

ENDP : 0.2926 (-5.00%)

Business Summary

Endo International plc is a global specialty pharmaceutical company, which is focused on branded and generic pharmaceuticals. The four reportable business segments are: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. The Branded...

See More

Key Turning Points

3rd Resistance Point 0.3309
2nd Resistance Point 0.3184
1st Resistance Point 0.3055
Last Price 0.2926
1st Support Level 0.2801
2nd Support Level 0.2676
3rd Support Level 0.2547

See More

52-Week High 7.0652
Fibonacci 61.8% 4.4733
Fibonacci 50% 3.6726
Fibonacci 38.2% 2.8719
Last Price 0.2926
52-Week Low 0.2800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar